Antonio Linares
Hims is Becoming the Tesla of Healthcare.
11/5/2025, 2:01:53 PM
Bullish
- Peptides have decades of data, facilitating faster deployment and understanding.
- Machine learning could identify better-performing molecular shapes, improving therapies.
Bearish
- AI may propose optimal molecules that do not actually exist, making recommendations impractical.
- Searching for a nonexistent ideal peptide could waste R&D resources and slow progress.
- Regulatory or administrative deployment could be premature, risking safety or misuse.